A detailed history of Manchester Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 22,248 shares of ABBV stock, worth $3.91 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
22,248
Previous 21,981 1.21%
Holding current value
$3.91 Million
Previous $3.77 Million 16.53%
% of portfolio
0.53%
Previous 0.46%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $43,745 - $53,221
267 Added 1.21%
22,248 $4.39 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $11,454 - $13,376
-74 Reduced 0.34%
21,981 $3.77 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $402,426 - $458,527
2,518 Added 12.89%
22,055 $4.02 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $94,668 - $106,619
-688 Reduced 3.4%
19,537 $3.03 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $6,545 - $7,577
-49 Reduced 0.24%
20,225 $3.01 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $419,526 - $522,073
-3,166 Reduced 13.51%
20,274 $2.73 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $305,994 - $352,398
2,116 Added 9.92%
23,440 $3.74 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $897,770 - $1.08 Million
6,491 Added 43.76%
21,324 $3.45 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $102,670 - $117,756
765 Added 5.44%
14,833 $1.99 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $8,945 - $11,372
-65 Reduced 0.46%
14,068 $2.16 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $32,229 - $40,779
300 Added 2.17%
14,133 $1.91 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $130,659 - $148,317
1,228 Added 9.74%
13,833 $1.49 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $85,956 - $95,760
817 Added 6.93%
12,605 $1.42 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $8,286 - $9,122
-81 Reduced 0.68%
11,788 $1.28 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $4,024 - $5,433
50 Added 0.42%
11,869 $1.27 Million
Q3 2020

Oct 27, 2020

SELL
$85.91 - $100.83 $284,104 - $333,444
-3,307 Reduced 21.86%
11,819 $1.04 Million
Q2 2020

Sep 28, 2020

BUY
$73.37 - $98.18 $53,339 - $71,376
727 Added 5.05%
15,126 $1.49 Million
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $27,900 - $33,543
-443 Reduced 2.98%
14,399 $1.09 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $44,972 - $52,930
-583 Reduced 3.78%
14,842 $1.2 Million
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $856,770 - $1.01 Million
9,543 Added 162.24%
15,425 $1.43 Million
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $51,249 - $68,627
-557 Reduced 8.65%
5,882 $557,000
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $449,764 - $574,487
6,439
6,439 $572,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.